| Literature DB >> 30370155 |
Thi-Hai-Yen Nguyen1,2, Mélanie Bertin1, Julie Bodin1, Natacha Fouquet1,3, Nathalie Bonvallot4, Yves Roquelaure1.
Abstract
BACKGROUND: Workers may be exposed to various types of occupational hazards at the same time, potentially increasing the risk of adverse health outcomes. The aim of this review was to analyze the effects of multiple occupational exposures and coexposures to chemical, biomechanical, and physical hazards on adverse health outcomes among agricultural workers.Entities:
Keywords: Agricultural workers; Coexposures; Multiple exposures; Occupational hazards
Year: 2018 PMID: 30370155 PMCID: PMC6129995 DOI: 10.1016/j.shaw.2018.04.002
Source DB: PubMed Journal: Saf Health Work ISSN: 2093-7911
Fig. 1PRISMA flow chart for identifying studies for systematic literature search. AHS, Agricultural Health Study; NIOSH, National Institute for Occupational Safety and Health.
Description and characteristics of the studies included in the systematic review (N = 15).
| Hazards | Population | Study design | Statistical method | Confounders | Health outcomes | Reference |
|---|---|---|---|---|---|---|
| Acetochlor applicators | PC | Poisson regression | Age, race, state, applicator type, smoking status, family history of cancer, alcohol consumption, body mass index, use of an enclosed cab, and education correlated/associated pesticide use | Colorectal cancer: 1.03 (0.66–1.61) | Lerro et al (2015) | |
| Paddy farmer | CS | Independent | Age, sex, and tobacco use | DNA damage: | How et al (2015) | |
| Farmers | CS | Linear regression model | Age, sex, history of smoking, and socioeconomic status | DNA damage: 2.28 (2.07–2.50) | Bhalli et al (2009) | |
| Cotton pickers | CS | Negative binomial regression Means ratio (95% CI) | Age | Cytogenetic damage: binucleated cells/total micronuclei: | Ali et al (2008) | |
| Farmers | CC | Logistic model | Age, family history of prostate cancer, and interview type | Prostate cancer: | Settimi et al (2003) | |
| Pesticide sprayer | CS | Chi-square test | Age and sex | Chromosome aberrations: | Kourakis et al (1996) | |
| Farm residents | PC | Logistic regression | Age, marital status, comorbidity including diabetes and history of cardiovascular disease | Prostate cancer: 2.23 (1.15–4.33) | Sharma et al (2015) | |
| Chlorpyrifos applicators | PC | Poisson regression | Age, sex, alcohol consumption, history of smoking, education level, family history of cancer, year of enrollment, state of residence, and use of the four pesticides which is most highly correlated with use of chlorpyrifos | Lung cancer: | Lee et al (2004) | |
| Farmers | CC | Logistic regression | Alcohol consumption, history of smoking status, education level, history of smoking a pipe, and respondent | Prostate cancer: | Band et al (2011) | |
| Farm women | PC | Logistic regression | Age, state, smoking status, body mass index, and “grew up on farm” | Asthma atopic | Hoppin et al (2008) | |
| Nonsmoking farm women | PC | Logistic regression | Age and state | Chronic bronchitis | Valcin et al (2007) | |
| Wheezing farmers | PC | Logistic regression | Age, state, smoking status, asthma, atopy, asthma with atopy, and current smoking with asthma | Wheezing | Hoppin et al (2004) | |
| Forestry workers | C | Log-binomial regression | Age-related hearing loss and exposure dose | Hearing loss | Turcot et al (2015) | |
| Farmers | CC | Logistic regression | Age and smoking status | Sick leave due to back disorder (SL-BP) | Hartman et al (2005) | |
| Agricultural tractor drivers | CC | Logistic regression | Age, body mass index, education, sport activity, car driving, marital status, mental stress, climatic conditions, and back trauma | Low back pain: | Bovenzi & Betta (1994) | |
C, cohort study; CC, case–control study; Cl, clinical; CS, cross-sectional study; F, female; I, interview; M, male; MQ, mailed questionnaire; MR, medical record; PC, prospective cohort study; Q, questionnaire; TI, telephone interview.
OR: Odds ratio; PR: Prevalence ratio; RR: Relative risk; 95% CI: 95% Confidence interval.
Items and rating of the quality assessment tool for quantitative studies according to the Effective Public Health Practice Project (EPHPP).
| Component | Rate this section | ||
|---|---|---|---|
| Strong | Moderate | Weak | |
| Are the individuals selected to participate in the study likely to be representative of the target population? | Very likely to be representative of the target population; more than 80% participation | Somewhat likely to be representative of the target population; a 60–79% participation rate | Not likely to be representative of the target population; less than 60% participation rate |
| What percentage of selected individuals agreed to participate? | |||
| Indicate the study design: … | Randomized controlled trials or controlled clinical trials | Cohort analytical study, case–control study, cohort design, or interrupted time series | Other method or study design not stated |
| Was the study described as randomized? | |||
| Was the method of randomization described? | |||
| Was the method appropriate? | |||
| Were there important differences between groups before the intervention? | Controlled for at least 80% of relevant confounders | Controlled for 60–79% of relevant confounders | Less than 60% of relevant confounders were controlled |
| Indicate the percentage of relevant confounders that were controlled: … | |||
| Was (were) the outcome assessor(s) aware of the intervention or exposure status of participants? | Not aware of the intervention status of participants for the outcome assessor; not aware of the research question for the participants | Not aware of the intervention status of participants for the outcome assessor; not aware of the research question for the participants | Aware of the intervention status of participants for the outcome assessor; aware of the research question for the participants |
| Were the study participants aware of the research question? | |||
| Are data collection tools shown to be valid? | Shown to be valid and reliable | Shown to be valid; not reliable or reliability not described | Not shown to be valid; both reliability and validity not described |
| Are data collection tools shown to be reliable? | |||
| Were withdrawals and dropouts reported in terms of numbers and/or reasons per group? | 80% or higher follow-up rate | 60–79% follow-up rate | Less than 60% follow-up rate or withdrawals and dropouts not described |
Characteristics of the studies included (n = 15).
| Characteristics of included studies | % | |
|---|---|---|
| Africa/America | 0 | 0.0 |
| Asia | 3 | 20.0 |
| Europe | 4 | 26.7 |
| United States/Canada | 8 | 53.3 |
| Case–control study | 4 | 26.7 |
| Cohort study | 7 | 46.7 |
| Cross-sectional study | 4 | 26.7 |
| Interview/Questionnaire | 10 | 66.7 |
| Medical records/Clinical examination | 2 | 13.3 |
| Mixed ≥ 2 types | 3 | 20.0 |
| Multiple biomechanical exposures | 0 | 0.0 |
| Multiple chemical exposures | 12 | 80.0 |
| Multiple physical exposures | 1 | 6.7 |
| Coexposures | 2 | 13.3 |
| 1990–1994 | 1 | 6.7 |
| 1995–1999 | 1 | 6.7 |
| 2000–2004 | 3 | 20.0 |
| 2005–2009 | 5 | 33.3 |
| 2010–2015 | 5 | 33.3 |
| Chi-square | 1 | 6.6 |
| 1 | 6.7 | |
| Logistic regression | 10 | 66.7 |
| Poisson regression | 2 | 13.3 |
| Regression model | 1 | 6.7 |
| Cancer | 5 | 33.3 |
| DNA and cytogenetic damage | 4 | 26.7 |
| Respiratory diseases | 3 | 20.0 |
| Musculoskeletal disorders | 2 | 13.3 |
| Hearing loss | 1 | 6.7 |
Results of quality assessment of the studies included following EPHPP six-item protocol.
| Author | Rating for each item | Global rating for the article | |||||
|---|---|---|---|---|---|---|---|
| A) Selection bias | B) Study design | C) Confounders | D) Blinding | E) Data collection methods | F) Withdrawals and dropouts | ||
| Lerro et al (2015) | M | M | S | M | M | M | S |
| How et al (2015) | S | W | S | S | S | M | M |
| Bhalli et al (2009) | M | W | S | S | S | W | W |
| Ali et al (2008) | W | W | W | M | M | S | W |
| Settimi et al (2003) | S | M | W | M | M | S | M |
| Kourakis et al (1996) | M | W | S | S | M | W | W |
| Sharma et al (2015) | M | M | S | M | M | M | S |
| Lee et al (2004) | W | M | S | M | M | M | M |
| Band et al (2011) | M | M | S | M | M | W | M |
| Hoppin et al (2008) | M | M | S | M | M | M | S |
| Valcin et al (2007) | M | M | S | M | M | M | S |
| Hoppin et al (2004) | W | M | S | M | M | M | M |
| Turcot et al (2015) | S | M | S | S | S | M | S |
| Hartman et al (2005) | M | M | S | M | M | W | M |
| Bovenzi & Betta (1994) | S | M | S | M | M | S | S |
| Strong | 4 (26.7) | 0 (0.0) | 13 (86.7) | 4 (26.7) | 3 (20.0) | 3 (20.0) | 6 (40.0) |
| Moderate | 8 (53.3) | 11 (73.3) | 0 (0.0) | 11 (73.3) | 12 (80.0) | 8 (53.3) | 6 (40.0) |
| Weak | 3 (20.0) | 4 (26.7) | 2 (13.3) | 0 (0.0) | 0 (0.0) | 4 (26.7) | 3 (20.0) |
EPHPP, Effective Public Health Practice Project; M, moderate; S, strong; W, weak.